Intimation of Analysts/Investors Conference Call to be held on May 19, 2026 at 5:00 P.M. to discuss Q4 FY26 financial results.
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kwality Pharmaceuticals has announced a conference call scheduled for May 19, 2026 at 5:00 PM to discuss its Q4 FY26 financial results. The call is part of the company's regular investor engagement activities and will be hosted by Go India Advisors. This disclosure is made under SEBI's Regulation 30 (Listing Obligations and Disclosure Requirements) Regulations, 2015. The announcement was signed by Managing Director Ramesh Kumar and filed with BSE on May 14, 2026. No specific financial figures or guidance details are provided in this intimation.
This is a routine investor relations disclosure with no material impact on the stock. It confirms the company is following proper disclosure norms and will discuss Q4 FY26 performance, but does not contain any new financial information or guidance changes.